Evidence map›Paper›PMID 31925628›Full record

ArticleClinical rheumatology2020

Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.

Théo Ghelfenstein Ferreira, François Delhommeau, Catherine Johanet, Grigorios Gerotziafas, Marie Bornes, Jonathan Cohen, Gilles Kayem, Olivier Fain, Virginie Planche, Arsene Mékinian

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. [Lupus and thrombophilia : Antiphospholipid syndrome].Zeitschrift fur Rheumatologie · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Théo Ghelfenstein FerreiraSorbonne Université, Service de Hématologie biologique, APHP, Hopital SAint Antoine,, 75012, Paris, France.
François DelhommeauSorbonne Université, Service de Hématologie biologique, APHP, Hopital SAint Antoine,, 75012, Paris, France.
Catherine JohanetSorbonne Université, Service de Hématologie biologique, APHP, Hopital SAint Antoine,, 75012, Paris, France.
Grigorios GerotziafasService d'hématologie biologique, Hôpital Tenon, AP-HP, 4 rue de la Chine, 75020, Paris, France.
Marie BornesService de Gynécologie Obstétrique et Médecine de la Reproduction, Hôpital Tenon, AP-HP, 4 rue de la Chine, 75020, Paris, France.
Jonathan CohenService de Gynécologie Obstétrique et Médecine de la Reproduction, Hôpital Tenon, AP-HP, 4 rue de la Chine, 75020, Paris, France.
Gilles KayemService de Gynécologie Obstétrique, Hôpital Armand-Trousseau, 26, avenue du Docteur-Arnold-Netter, 75012, Paris, France.
Olivier FainSorbonne Université, Service de Médecine Interne, APHP SAint Antoine, 75012, Paris, France.
Virginie Planche *Sorbonne Université, Service de Hématologie biologique, APHP, Hopital SAint Antoine,, 75012, Paris, France.
Arsene Mékinian *Sorbonne Université, Service de Médecine Interne, APHP SAint Antoine, 75012, Paris, France. arsene.mekinian@aphp.fr.
Assistance Publique – Hôpitaux de Paris · FRSorbonne Université · FRHôpital Armand-Trousseau · FRHôpital Saint-Antoine · FRHôpital Tenon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we aimed to analyze the value of annexin-A5 anticoagulant ratio (A5R) and non-criteria antibodies for the diagnosis of APS in patients with clinical seronegative APS. Three groups were defined, including 21 seronegative APS patients with unexplained obstetrical adverse events or thrombosis history, 15 confirmed APS patients with triple aPL positivity, and a control group of 20 healthy patients without any history of thrombosis or pregnancy complications. Seronegative APS patients have similar levels of A5R in comparison to healthy controls (202% [171%-238%] versus 191% [178%-221%]; p = 0.65), whereas triple-positive APS patients have significantly more reduced A5R in comparison to both seronegative and healthy patients (149% [138%-158%] versus 202% [171%-238%] and 191% [178%-221%], respectively, p < 0.001). The non-criteria aPL were found in 24% of seronegative APS: anti-PE IgM in 3 cases (14%) and anti-PS/PT IgG and anti-PS/PT IgM in 1 (5%) case each. The frequency of non-criteria APL was significantly more frequent in comparison to healthy controls (p = 0.048). All triple-positive APS patients have at least one non-criteria aPL, and the non-criteria aPL were significantly more frequent in these patients compared to seronegative APS and healthy controls (p < 0.001). Whereas A5R levels do not allow to discriminate seronegative APS from healthy controls, our results demonstrate that non-criteria aPL can help to APS diagnosis in clinical seronegative APS.Key points• Annexin-A5 resistance testing does not help for the diagnosis of seronegative APS.• The non-criteria antiphospholipid antibodies can contribute to APS diagnosis in patients without conventional antibodies.

Indexed as

AdultAnnexin A5Antibodies, AntiphospholipidAnticoagulantsAntiphospholipid SyndromeCase-Control StudiesFemaleHumansMaleMiddle AgedPregnancyPregnancy Complications, CardiovascularThrombosisAnnexin A5Antibodies, AntiphospholipidAnticoagulantsAnnexin-A5Annexin-A5 resistanceAntiphospholipid antibodiesAntiphospholipid syndromeNon-criteria antibodiesSeronegative

Identifiers

PMID31925628
OpenAlexW3000693967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.